# LRCH2

## Overview
LRCH2 is a gene that encodes the protein leucine-rich repeats and calponin homology domain containing 2, which is involved in various cellular processes, particularly those related to cytoskeletal organization and immune response regulation. The protein is characterized by the presence of leucine-rich repeat (LRR) and calponin homology (CH) domains, which facilitate protein-protein interactions and actin binding, respectively, suggesting its role in cytoskeletal dynamics and cellular motility (Rivière2020Structure). LRCH2 is implicated in immune responses and has been associated with inflammatory conditions, as well as cancer progression, particularly in metastatic lung cancer and renal cell carcinoma (Dai2023Lung; Caliskan2020Novel). Its expression levels are linked to immune cell infiltration in tumors, indicating a potential role in modulating the tumor microenvironment (Dai2023Lung). Despite these insights, further research is needed to fully elucidate the specific functions and interactions of LRCH2 in both normal and pathological contexts.

## Function
LRCH2 is a protein characterized by the presence of leucine-rich repeat (LRR) and calponin homology (CH) domains, which are crucial for protein-protein interactions and actin binding, respectively. These domains suggest that LRCH2 plays a significant role in cytoskeletal organization and regulation, particularly in the reorganization of the actin cytoskeleton. This function is essential for various cellular processes, including cell polarization, migration, and vesicular dynamics, which are critical for leukocyte functions (Rivière2020Structure).

LRCH2 is also implicated in immune response regulation. Its expression is modulated in leukocytes under inflammatory conditions, indicating a potential role in host defense mechanisms (Rivière2020Structure). The protein may interact with DOCK proteins, which are known to regulate the cytoskeleton, suggesting that LRCH2 could influence cytoskeletal dynamics through these interactions (Rivière2020Structure).

In the context of cancer, LRCH2 is identified as a down-regulated gene in metastatic lung cancer, with its expression levels inversely associated with immune cell infiltration in the tumor microenvironment. This suggests that LRCH2 may influence the immune landscape of tumors, potentially affecting cancer progression (Dai2023Lung). However, specific functions of LRCH2 in healthy human cells remain to be fully elucidated.

## Clinical Significance
LRCH2 has been implicated in various diseases due to its altered expression and potential role in tumorigenesis. In metastatic lung cancer, LRCH2 is significantly down-regulated compared to primary lung cancer, and its lower expression is associated with shorter survival times in patients. This suggests that LRCH2 may serve as a prognostic biomarker for disease progression and a potential drug target (Dai2023Lung). The gene's expression is also correlated with immune cell infiltration levels, including B cells, CD8+ T cells, and macrophages, indicating its role in shaping the tumor immune microenvironment (Dai2023Lung).

In renal cell carcinoma, particularly in kidney chromophobe (KICH) subtype, LRCH2 has been identified as a hub protein, suggesting its involvement in the disease's progression. However, specific clinical implications of LRCH2 mutations or expression changes in this context require further investigation (Caliskan2020Novel).

Additionally, genomic analyses have linked gene amplifications of LRCH2 to tumorigenesis in gliomas and melanomas, highlighting its potential role in cancer development (Rivière2020Structure). These findings underscore the importance of LRCH2 in cancer biology and its potential as a therapeutic target.

## Interactions
LRCH2, a protein characterized by leucine-rich repeats and a calponin homology domain, is involved in various cellular processes, including protein-protein interactions. The leucine-rich repeat domain is known for facilitating interactions with other proteins, while the calponin homology domain is associated with actin binding, suggesting a role in cytoskeletal regulation (Rivière2020Structure).

In the context of renal cell carcinoma, LRCH2 has been identified as a hub protein in the protein-protein interaction (PPI) network for the KICH subtype, indicating its potential involvement in significant regulatory pathways within this cancer type (Caliskan2020Novel). However, specific interactions or roles of LRCH2 within this network are not detailed in the available data (Caliskan2020Novel).

LRCH2 is also implicated in immune responses, as it shares peptides with human cytomegalovirus (HCMV) proteins, which may contribute to immune crossreactivity and potential autoimmune responses (Lucchese2018Cytomegalovirus). Despite these insights, detailed interactions of LRCH2 with specific proteins or nucleic acids remain largely unexplored, highlighting the need for further research to elucidate its precise functional roles and interaction partners.


## References


[1. (Lucchese2018Cytomegalovirus) Guglielmo Lucchese and Darja Kanduc. Cytomegalovirus infection: the neurodevelopmental peptide signatures. Current Drug Discovery Technologies, 15(3):251–262, July 2018. URL: http://dx.doi.org/10.2174/1570163814666170829152100, doi:10.2174/1570163814666170829152100. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.2174/1570163814666170829152100)

2. (Dai2023Lung) Lung cancer and miRNAs: a possible remedy for anti-metastatic, therapeutic and diagnostic applications. This article has 0 citations.

[3. (Caliskan2020Novel) Aysegul Caliskan, Ahmet Cenk Andac, and Kazim Yalcin Arga. Novel molecular signatures and potential therapeutics in renal cell carcinomas: insights from a comparative analysis of subtypes. Genomics, 112(5):3166–3178, September 2020. URL: http://dx.doi.org/10.1016/j.ygeno.2020.06.003, doi:10.1016/j.ygeno.2020.06.003. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ygeno.2020.06.003)

[4. (Rivière2020Structure) Thibaud Rivière, Almke Bader, Kristin Pogoda, Barbara Walzog, and Daniela Maier-Begandt. Structure and emerging functions of lrch proteins in leukocyte biology. Frontiers in Cell and Developmental Biology, September 2020. URL: http://dx.doi.org/10.3389/fcell.2020.584134, doi:10.3389/fcell.2020.584134. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2020.584134)